Edwards Lifesciences Corp. (E1WL34)
Market Closed
7 Aug, 19:55
B3 B3 Primary R$
105. 71
0
0%
R$
243.47B Market Cap
- P/E Ratio
- Div Yield
303 Volume
0 Eps
R$ 105.71
Previous Close Want to track E1WL34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Edwards Lifesciences Corp. (E1WL34) Statistics
Valuation metrics
Market Cap 243.47B
Enterprise value 295.02B
Trailing P/E (ttm) 46
Forward P/E -
PEG ratio 5.61
Price/Sales (ttm) 39.16
Price/Book (mrq) 4.75
Enterprise Value/Revenue 9.32
Enterprise Value/EBITDA 30.86
Overview
Shares outstanding 577M
Float 573.97M
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 103
Average volume (90 days) 509
Price summary
52-Week low 94.3
52-Week high 122.51
Beta 0.87
50-Day moving average 103.33
200-Day moving average 107.4
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 3:1
Last split Date 1 Jun 2020
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.17%
Operating margin 0.31%
Operational effectiveness
Return on assets 0.08%
Return on equity 0.1%
Income Statement
Revenue (ttm) 31.66B
Revenue per share (ttm) 2.7
Quarterly revenue growth (yoy) 0.17%
Gross profit (ttm) 24.65B
EBITDA 2.22B
Net income to common (ttm) 5.4B
Diluted EPS (ttm) 2.33
Quarterly earnings growth (yoy) 0.06%
Balance Sheet
Total cash (mrq) 18.44B
Total cash per share (mrq) 6.38
Total debt (mrq) 3.53B
Total Debt/Equity (mrq) 6.81
Current ratio (mrq) 4.42%
Book value per share (mrq) 22.55
Cash Flow
Cash flow statement 6.82B
Levered free cash flow (LFCF) 4.53B
